drugset / Trial / NCT02971605
Persisting Effects of Psilocybin
Phase 1/2
Completed
13 enrolled
Johns Hopkins University
National Institute on Drug Abuse (NIDA) · collab
NaSingle-groupOpen-labelBasic science
Summary
The proposed pilot study will assess whether ingestion of a classic hallucinogen (psilocybin) leads to changes in emotion processing and neural circuitry that may predict repeated self-administration of this drug and underlie an atypical mechanism of abuse liability, which may vitally contribute to the understanding of the potential for abuse and the underlying mechanisms supporting abuse of classic hallucinogens.
Timeline
- Start
- 2017-07-01
- Primary completion
- 2018-08-21
- Completion
- 2018-08-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 25 mg | — |
Indications
No indication recorded.